Akebia Therapeutics (AKBA)'s 30-day implied volatility (IV30) was 69.2% at the close on October 22, 2026, down from 73.5% the day before, against a 52-week range of 45.6% to 124.5%. Its 20-day historical volatility was 70.7%.
Data as of October 22, 2026.